Works matching IS 13960296 AND DT 2022 AND VI 35 AND IP 8
Results: 76
Assessing the use of methotrexate as an alternate therapy for pemphigus vulgaris and pemphigus foliaceus.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15661
- By:
- Publication type:
- Article
Refractory livedoid vasculopathy in a child successfully treated with baricitinib.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15659
- By:
- Publication type:
- Article
The application prospects of honokiol in dermatology.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15658
- By:
- Publication type:
- Article
Clinical efficacy of microwave in the treatment of axillary osmidrosis and primary hyperhidrosis.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15657
- By:
- Publication type:
- Article
Comparison of overall efficacy and safety of oral versus subcutaneous methotrexate in severe psoriasis.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15656
- By:
- Publication type:
- Article
Orbital vascular malformation: Successful outcome in two patients treated with rapamycin.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15655
- By:
- Publication type:
- Article
An ultrapulsed CO<sub>2</sub> laser combined with a long‐pulsed Nd:YAG laser for the treatment of oral and maxillofacial pyogenic granuloma.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15654
- By:
- Publication type:
- Article
Dupilumab combined with low‐dose systemic steroid therapy improves efficacy and safety for bullous pemphigoid.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15648
- By:
- Publication type:
- Article
Surgery combined with photodynamic therapy versus surgery alone for the treatment of non‐melanoma skin cancer and actinic keratosis: A retrospective cohort study.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15652
- By:
- Publication type:
- Article
Cutaneous manifestations following COVID‐19 vaccination: A report of 25 cases.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15651
- By:
- Publication type:
- Article
A case report of a piperacillin/tazobactam‐induced acute generalized exanthematous pustulosis.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15650
- By:
- Publication type:
- Article
Mammalian target of rapamycin inhibitors for prolonged secondary prevention of nonmelanoma skin cancer in solid organ transplant recipients.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15649
- By:
- Publication type:
- Article
Fast and sustained improvement of patient‐reported outcomes in psoriatic patients treated with secukinumab in a daily practice setting.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15653
- By:
- Publication type:
- Article
Lasers for cutaneous lesions: An update.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15647
- By:
- Publication type:
- Article
Omalizumab as adjuvant therapy for pemphigus vulgaris.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15646
- By:
- Publication type:
- Article
Successfully and safety use of dupilumab in the management of severe atopic dermatitis and concomitant moderate‐to‐severe hidradenitis suppurativa.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15645
- By:
- Publication type:
- Article
Reply to "Switch from ustekinumab to guselkumab in patients with psoriasis in real clinical practice using the "minimal disease activity" parameter".
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15644
- By:
- Publication type:
- Article
Reply to Murgia et al., about "Switch from ustekinumab to guselkumab in patients with psoriasis in real clinical practice: A retrospective multicenter study using the "minimal disease activity" parameter".
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15643
- Publication type:
- Article
Successful treatment of refractory prurigo nodularis with baricitinib.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15642
- By:
- Publication type:
- Article
Recalcitrant granuloma annulare induced by two different biologic agents resolved after Janus kinase inhibitor treatment.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15641
- By:
- Publication type:
- Article
Analyzing and comparing recent disclosures and payments of dermatology clinical guideline authors.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15640
- By:
- Publication type:
- Article
Efficacy, safety, tolerability, and satisfaction of N‐acetylcysteine and pentoxifylline in lichen planopilaris patients under treatment with topical clobetasol: A triple arm blinded randomized controlled trial.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15639
- By:
- Publication type:
- Article
Apremilast: A novel adjuvant treatment for refractory isotretinoin‐induced acne fulminans.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15637
- By:
- Publication type:
- Article
Evaluation of combination use of phenytoin cream 1% and fractional CO<sub>2</sub> laser in treatment of stable nonsegmental vitiligo: A pilot study.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15635
- By:
- Publication type:
- Article
Long‐term disease control and safety with the anti‐CCR4 antibody mogamulizumab: Post‐hoc analyses from the MAVORIC trial of patients with previously treated cutaneous T‐cell lymphoma.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15634
- By:
- Publication type:
- Article
Classification and rising medication therapy in stiff skin syndrome: A case report and literature review.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15633
- By:
- Publication type:
- Article
Paradoxical inflammatory reaction to terbinafine in the setting of Majocchi's granuloma due to Trichophyton interdigitale.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15632
- By:
- Publication type:
- Article
Ulcerative injection site reaction after third COVID‐19 vaccine dose with mRNA‐1273.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15631
- By:
- Publication type:
- Article
Epidemiology, clinical presentation, and management of pemphigoid nodularis: An update from Iran.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15630
- By:
- Publication type:
- Article
More data on erythema annulare centrifugum induced by COVID‐19 vaccination.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15629
- By:
- Publication type:
- Article
Demographic aspects, clinical characteristics, and therapeutic approaches in geriatric psoriasis: A study from a tertiary center.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15628
- By:
- Publication type:
- Article
A pediatric case of recalcitrant nail psoriasis successfully treated with a single dose of intralesional triamcinolone acetonide.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15627
- By:
- Publication type:
- Article
Dissecting cellulitis of the scalp: A review on clinical characteristics and management options in a series of 14 patients.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15626
- By:
- Publication type:
- Article
Clinical efficacy of mychophenolate mofetil in treating lichen planopilaris.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15625
- By:
- Publication type:
- Article
Personal protective equipment‐related dermatoses in COVID‐19 frontline health workers. A lesson learned from 1‐year single center in the UAE.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15624
- By:
- Publication type:
- Article
Dupilumab for the treatment of pembrolizumab‐induced bullous pemphigoid: A case report.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15623
- By:
- Publication type:
- Article
Sociodemographic, clinical and therapeutic factors as predictors of life quality impairment in psoriasis: A cross‐sectional study in Italy.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15622
- By:
- Publication type:
- Article
Belimumab for the treatment of pemphigus.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15621
- By:
- Publication type:
- Article
Factors associated with efficacy of botulinum toxin a injections in primary axillary hyperhidrosis: A retrospective study of ninety patients.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15620
- By:
- Publication type:
- Article
A new combined surgical and medical technique for auricular keloids.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15619
- Publication type:
- Article
A case of cutaneous arteritis after administration of mRNA coronavirus disease 2019 vaccine.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15618
- By:
- Publication type:
- Article
New‐onset guttate psoriasis following coronavirus disease 2019 vaccination: About two cases.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15617
- By:
- Publication type:
- Article
Efficacy and safety of apremilast and its impact on serum cytokine levels in patients with Behçet's disease.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15616
- By:
- Publication type:
- Article
Power‐assisted rotary cutter with negative pressure suction through small incision for axillary osmidrosis.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15615
- By:
- Publication type:
- Article
Successful treatment of recalcitrant facial sebopsoriasis with low‐dose cyclosporine.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15614
- By:
- Publication type:
- Article
Urticarial vasculitis after COVID‐19 vaccination: A case report and literature review.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15613
- By:
- Publication type:
- Article
Efficacy and safety of PavéDerm J‐Fill for nasolabial folds: A phase III randomized, blinded, prospective, and split‐faced head‐to‐head trial.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15612
- By:
- Publication type:
- Article
The effect of electromagnetic field on decreasing and increasing of the growth and proliferation rate of dermal fibroblast cell.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15611
- Publication type:
- Article
Successful treatment with secukinumab in an HIV‐positive psoriatic patient after failure of apremilast.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15610
- By:
- Publication type:
- Article
Cryptococcal meningitis associated with interleukin‐17 inhibitor use for psoriasis.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15609
- By:
- Publication type:
- Article